FDAFDA · Food and drugs·Recall number D-0649-2016
Lyrica (pregabalin) capsules, 75 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1014-68
Published February 10, 2016 · Recall initiated: January 11, 2016
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- LYRICA
- Manufacturer
- Pfizer Inc.
- Distributor
- Nationwide and Puerto Rico
- UPC
- 0300711012683
- Lot
- Lot #: M07862, Exp 05/2018; M07865, Exp 06/2018
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.